Stephan Clavel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Stephan Clavel has a total of 105 co-authors. Here are the top co-authors by number of shared publications:
- Frédéric Bost
Université Côte d’Azur, INSERM U1065, C3M, Bâtiment Universitaire Archimed, 151 Route de Saint-Antoine de Ginestière, BP 2 3194, CEDEX 3, 06204 Nice, France
19 shared publications - Stéphanie Torrino
Université Côte d'Azur, CNRS, IPMC, Valbonne, France
17 shared publications Kathiane Laurent
16 shared publicationsLisa Kaminski
16 shared publicationsMaeva Gesson
16 shared publicationsEmilie Jaune
15 shared publications
Latest Publications
- 17 August 2023
- Published by Springer Nature in Oncogene
- Vol. 42 (38) , 2854-2867
Persistent organic pollutants promote aggressiveness in prostate cancer
Increasing evidence points towards a causal link between exposure to persistent organic pollutants (POPs) with increased incidence and aggressivity of various cancers. Among these POPs, dioxin and PCB-153 are widely found in our environment and represent a significant source of contamination. Dioxin exposure has already been linked to cancer such as non-Hodgkin’s lymphoma, but remains to be more extensively investigated in other cancers. Potential implications of dioxin and PCB-153 in prostate cancer progression spurred us to challenge both ex vivo and in vivo models with low doses of these POPs. We found that dioxin or PCB-153 exposure increased hallmarks of growth and metastasis of prostate cancer cells ex vivo and in grafted NOD-SCID mice. Exposure induced histopathological carcinoma-like patterns in the Ptenpc−/− mice. We identified up-regulation of Acetyl-CoA Acetyltransferase-1 (ACAT1) involved in ketone bodies pathway as a potential target. Mechanistically, genetic inhibition confirmed that ACAT1 mediated dioxin effect on cell migration. Using public prostate cancer datasets, we confirmed the deregulation of ACAT1 and associated gene encoded ketone bodies pathway enzymes such as OXCT1, BDH1 and HMGCL in advanced prostate cancer. To further explore this link between dioxin and ACAT1 deregulation, we analyzed a unique prostate-tumour tissue collection from the USA veterans exposed to agent orange, known to be highly contaminated by dioxin because of industrial production. We found that ACAT1 histoscore is significantly increased in exposed patients. Our studies reveal the implication of dioxin and PCB-153 to induce a prometastatic programme in prostate tumours and identify ACAT1 deregulation as a key event in this process.
- 17 August 2023
- Published by Springer Nature in Oncogene
- Vol. 42 (38) , 2854-2867
Persistent organic pollutants promote aggressiveness in prostate cancer
Increasing evidence points towards a causal link between exposure to persistent organic pollutants (POPs) with increased incidence and aggressivity of various cancers. Among these POPs, dioxin and PCB-153 are widely found in our environment and represent a significant source of contamination. Dioxin exposure has already been linked to cancer such as non-Hodgkin’s lymphoma, but remains to be more extensively investigated in other cancers. Potential implications of dioxin and PCB-153 in prostate cancer progression spurred us to challenge both ex vivo and in vivo models with low doses of these POPs. We found that dioxin or PCB-153 exposure increased hallmarks of growth and metastasis of prostate cancer cells ex vivo and in grafted NOD-SCID mice. Exposure induced histopathological carcinoma-like patterns in the Ptenpc−/− mice. We identified up-regulation of Acetyl-CoA Acetyltransferase-1 (ACAT1) involved in ketone bodies pathway as a potential target. Mechanistically, genetic inhibition confirmed that ACAT1 mediated dioxin effect on cell migration. Using public prostate cancer datasets, we confirmed the deregulation of ACAT1 and associated gene encoded ketone bodies pathway enzymes such as OXCT1, BDH1 and HMGCL in advanced prostate cancer. To further explore this link between dioxin and ACAT1 deregulation, we analyzed a unique prostate-tumour tissue collection from the USA veterans exposed to agent orange, known to be highly contaminated by dioxin because of industrial production. We found that ACAT1 histoscore is significantly increased in exposed patients. Our studies reveal the implication of dioxin and PCB-153 to induce a prometastatic programme in prostate tumours and identify ACAT1 deregulation as a key event in this process.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Data from PGC1α Inhibits Polyamine Synthesis to Suppress Prostate Cancer Aggressiveness
Although tumorigenesis is dependent on the reprogramming of cellular metabolism, the metabolic pathways engaged in the formation of metastases remain largely unknown. The transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) plays a pleiotropic role in the control of cancer cell metabolism and has been associated with a good prognosis in prostate cancer. Here, we show that PGC1α represses the metastatic properties of prostate cancer cells via modulation of the polyamine biosynthesis pathway. Mechanistically, PGC1α inhibits the expression of c-MYC and ornithine decarboxylase 1 (ODC1), the rate-limiting enzyme for polyamine synthesis. Analysis of in vivo metastases and clinical data from patients with prostate cancer support the proposition that the PGC1α/c-MYC/ODC1 axis regulates polyamine biosynthesis and prostate cancer aggressiveness. In conclusion, downregulation of PGC1α renders prostate cancer cells dependent on polyamine to promote metastasis.Significance:These findings show that a major regulator of mitochondrial metabolism controls polyamine synthesis and prostate cancer aggressiveness, with potential applications in therapy and identification of new biomarkers.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessData from PGC1α Inhibits Polyamine Synthesis to Suppress Prostate Cancer Aggressiveness
Although tumorigenesis is dependent on the reprogramming of cellular metabolism, the metabolic pathways engaged in the formation of metastases remain largely unknown. The transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) plays a pleiotropic role in the control of cancer cell metabolism and has been associated with a good prognosis in prostate cancer. Here, we show that PGC1α represses the metastatic properties of prostate cancer cells via modulation of the polyamine biosynthesis pathway. Mechanistically, PGC1α inhibits the expression of c-MYC and ornithine decarboxylase 1 (ODC1), the rate-limiting enzyme for polyamine synthesis. Analysis of in vivo metastases and clinical data from patients with prostate cancer support the proposition that the PGC1α/c-MYC/ODC1 axis regulates polyamine biosynthesis and prostate cancer aggressiveness. In conclusion, downregulation of PGC1α renders prostate cancer cells dependent on polyamine to promote metastasis.Significance:These findings show that a major regulator of mitochondrial metabolism controls polyamine synthesis and prostate cancer aggressiveness, with potential applications in therapy and identification of new biomarkers.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S3 from PGC1α Inhibits Polyamine Synthesis to Suppress Prostate Cancer Aggressiveness
The downregulation of ODC1 inhibits PCa aggressiveness in ShPGC-1a cells
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from PGC1α Inhibits Polyamine Synthesis to Suppress Prostate Cancer Aggressiveness
The downregulation of ODC1 inhibits PCa aggressiveness in ShPGC-1a cells
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Data from PGC1α Inhibits Polyamine Synthesis to Suppress Prostate Cancer Aggressiveness
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from PGC1α Inhibits Polyamine Synthesis to Suppress Prostate Cancer Aggressiveness
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S4 from PGC1α Inhibits Polyamine Synthesis to Suppress Prostate Cancer Aggressiveness
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from PGC1α Inhibits Polyamine Synthesis to Suppress Prostate Cancer Aggressiveness
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S5 from PGC1α Inhibits Polyamine Synthesis to Suppress Prostate Cancer Aggressiveness
PGC-1a, c-MYC and ODC1 expression in the Taylor database
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from PGC1α Inhibits Polyamine Synthesis to Suppress Prostate Cancer Aggressiveness
PGC-1a, c-MYC and ODC1 expression in the Taylor database
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S1 from PGC1α Inhibits Polyamine Synthesis to Suppress Prostate Cancer Aggressiveness
PGC-1a suppresses PCa cell aggressiveness and polyamine synthesis
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from PGC1α Inhibits Polyamine Synthesis to Suppress Prostate Cancer Aggressiveness
PGC-1a suppresses PCa cell aggressiveness and polyamine synthesis
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S2 from PGC1α Inhibits Polyamine Synthesis to Suppress Prostate Cancer Aggressiveness
PGC-a regulates c-MYC and ODC1 expression
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from PGC1α Inhibits Polyamine Synthesis to Suppress Prostate Cancer Aggressiveness
PGC-a regulates c-MYC and ODC1 expression
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S4 from PGC1α Inhibits Polyamine Synthesis to Suppress Prostate Cancer Aggressiveness
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from PGC1α Inhibits Polyamine Synthesis to Suppress Prostate Cancer Aggressiveness
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S3 from PGC1α Inhibits Polyamine Synthesis to Suppress Prostate Cancer Aggressiveness
The downregulation of ODC1 inhibits PCa aggressiveness in ShPGC-1a cells
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from PGC1α Inhibits Polyamine Synthesis to Suppress Prostate Cancer Aggressiveness
The downregulation of ODC1 inhibits PCa aggressiveness in ShPGC-1a cells